Exploring SGLT2 Inhibitors SGLT2 inhibitors, including empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), offer a different therapeutic pathway
Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial
The exact cause of NAION isnt clear, but its believed to be caused by reduced blood flow to the optic nerve head
Neuroprotection and Cognitive Enhancement: Peptide therapy offers potential benefits for brain health by protecting nerve cells, encouraging nerve regeneration, and improving cognitive functions
So, we connect you with experienced, independent health providers who take a patient-centered approach, customizing treatment plans that fit your lifestyle, medical history, and your goals
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease